May 17, 2021 5:15pm EDT Vyant Bio Reports First Quarter 2021 Results and Provides Strategic Business Update
May 13, 2021 8:00am EDT Vyant Bio Announces Investor Conference Call and Webcast for First Quarter 2021
Apr 22, 2021 8:00am EDT Vyant Bio, Inc., Ordaōs Bio, and Cellaria, Inc. Announce Collaboration to Design and Qualify Biomarker-Specific Small Protein Therapeutics
Apr 01, 2021 5:45pm EDT Vyant Bio Announces Investor Webcast to Provide Updates Post Merger between Cancer Genetics and StemoniX
Mar 25, 2021 9:15am EDT Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX
Mar 18, 2021 8:30am EDT Cancer Genetics Announces Roland J. Carrillo, PhD as Vice President of Business Development
